On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On Jan. 13, 2026, BriaCell Therapeutics announces the durable and sustained complete resolution of a lung metastasis in…
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Jul. 7, 2025, Celltrion announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab)…
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…
On Jan. 10, 2025, researchers at Roswell Park Comprehensive Cancer Center have identified a previously unknown cause of…
On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Oct. 10, 2024, Genentech announced that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib), in…
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…